Aurinia Pharmaceuticals Inc. (AUPH) NASDAQ

$5.01 0.01 (0.20%)

Market Cap: $724.53M

As of 03/28/24 04:00 PM EDT. Market closed.

(AUPH)

Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ

$5.01
0.01 (0.20%)

Market Cap: $724.53M

As of 03/28/24 04:00 PM EDT. Market closed.

Add to Portfolio

aurinia pharmaceuticals is a biotechnology company located in 5120-75 street, edmonton, ... read more

aurinia pharmaceuticals is a biotechnology company located in 5120-75 street, edmonton, canada. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
1203-4464 Markham St, British Columbia, Victoria, V8Z 7X8.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Peter Greenleaf
Address
1203-4464 Markham St, British Columbia, Victoria, V8Z 7X8.
PRICE CHART FOR AURINIA PHARMACEUTICALS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$4.97
Previous Close
$5
Days Range
$4.86 - $5.01
52 week range
$4.85 - $12.43
Volume
1,375,006
Avg. Volume (30 days)
1,622,416
Market Cap
$724.53M
Dividend Yield
-
P/E
-
Shares Outstanding
144,617,762
Open
$4.97
Previous Close
$5
Days Range
$4.86 - $5.01
52 week range
$4.85 - $12.43
Volume
1,375,006
Avg. Volume (30 days)
1,622,416
Market Cap
$724.53M
Dividend Yield
-
P/E
-
Shares Outstanding
144,617,762
FINANCIAL STATEMENTS FOR AURINIA PHARMACEUTICALS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR AURINIA PHARMACEUTICALS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Greenleaf PeterChief Executive OfficerMar 06, 2024 Sale$5.60126,981711,0941,522,114Mar 07, 2024, 04:46 PM
Miller Joseph MChief Financial OfficerMar 06, 2024 Sale$5.6034,811194,942495,928Mar 07, 2024, 04:44 PM
Donley Matthew MaxwellEVP, Ops & StrategyMar 06, 2024 Sale$5.5140,665224,064584,072Mar 07, 2024, 04:43 PM
Habig Scott MichaelChief Commercial OfficerMar 06, 2024 Sale$5.6017,77799,551474,587Mar 07, 2024, 04:42 PM
Robertson Stephen P.EVP, General CounselMar 06, 2024 Sale$5.6057,745323,372443,824Mar 07, 2024, 04:41 PM
Knappertz VolkerEVP, Research and DevelopmentFeb 27, 2024 Sale$6.104,93030,073319,128Feb 29, 2024, 04:11 PM
Knappertz VolkerEVP, Research and DevelopmentFeb 20, 2024 Sale$5.4825,146137,800324,058Feb 22, 2024, 04:35 PM
Habig Scott MichaelChief Commercial OfficerFeb 20, 2024 Sale$5.4815,86786,951492,364Feb 22, 2024, 04:33 PM
Robertson Stephen P.EVP, General CounselMar 02, 2023 Sale$8.7819,644172,474303,122Feb 22, 2024, 04:19 PM
Miller Joseph MChief Financial OfficerMar 02, 2023 Sale$8.7811,398100,074331,112Feb 22, 2024, 04:17 PM
Jayne David R.W.DirectorMay 23, 2023 Sale$11.268,73398,33449,310May 23, 2023, 05:19 PM
Hagan Joseph PDirectorMay 19, 2023 Sale$10.582722,87811,961May 23, 2023, 05:18 PM
Billen DanielDirectorMay 23, 2023 Sale$11.264,65052,35933,393May 23, 2023, 05:17 PM
MacKay-Dunn R. HectorDirectorMay 23, 2023 Sale$11.264,81854,25124,225May 23, 2023, 05:16 PM
Leversage JillDirectorMay 23, 2023 Sale$11.264,81554,21718,528May 23, 2023, 05:14 PM
MILNE GEORGE M JRDirectorMar 02, 2023 Buy$8.9120,000178,28470,000Mar 06, 2023, 04:29 PM
Miller Joseph MChief Financial OfficerMar 02, 2023 Sale$8.9411,296100,986331,214Mar 06, 2023, 04:29 PM
Robertson Stephen P.EVP, General CounselMar 02, 2023 Sale$8.9419,402173,454303,364Mar 06, 2023, 04:29 PM
Greenleaf PeterChief Executive OfficerMar 02, 2023 Sale$8.9432,750292,785982,968Mar 06, 2023, 04:27 PM
Donley Matthew MaxwellEx VP, Internal OperationsNov 21, 2022 Buy$4.6610,00046,60027,927Nov 23, 2022, 04:04 PM
Habig Scott MichaelChief Commercial OfficerNov 09, 2022 Buy$5.015,00025,0755,000Nov 14, 2022, 04:31 PM
Martin Michael RobertChief Business OfficerNov 07, 2022 Buy$5.1630,000154,80089,512Nov 09, 2022, 04:05 PM
Jayne David R.W.DirectorMay 18, 2022 Option Exercise$3.6210,00036,20040,000Jul 11, 2022, 06:16 AM
MacKay-Dunn R. HectorDirectorMar 09, 2022 Buy$11.005,00054,98511,000Mar 11, 2022, 04:05 PM
MILNE GEORGE M JRDirectorMar 04, 2022 Buy$10.825,00054,10050,000Mar 08, 2022, 04:06 PM
Martin Michael RobertChief Business OfficerMar 02, 2022 Sale$12.014,84958,23659,512Mar 04, 2022, 04:13 PM
Donley Matthew MaxwellEx VP, Intern'l OperationsMar 02, 2022 Sale$12.013,05236,65516,224Mar 04, 2022, 04:12 PM
Miller Joseph MChief Financial OfficerMar 02, 2022 Sale$12.013,06036,7516,610Mar 04, 2022, 04:12 PM
Colao MassimilanoChief Commercial OfficerMar 02, 2022 Sale$12.013,20538,49213,495Mar 04, 2022, 04:11 PM
Greenleaf PeterChief Executive OfficerMar 02, 2022 Sale$12.019,068108,90732,967Mar 04, 2022, 04:11 PM
Solomons NeilChief Medical OfficerMar 02, 2022 Sale$12.014,84658,20090,953Mar 04, 2022, 04:10 PM
Huizinga Robert BindertEVP of ResearchMar 02, 2022 Sale$12.014,84958,23669,379Mar 04, 2022, 04:10 PM
Leversage JillDirectorDec 13, 2021 Buy$20.041,60032,0645,300Dec 15, 2021, 04:09 PM
Martin Michael RobertChief Business OfficerNov 11, 2021 Option Exercise$18.3829,000533,02095,861Nov 12, 2021, 04:18 PM
Martin Michael RobertChief Business OfficerNov 10, 2021 Sale$31.1460,0001,868,50076,861Nov 12, 2021, 04:18 PM
Martin Michael RobertChief Business OfficerNov 09, 2021 Sale$30.1750,0001,508,500126,861Nov 12, 2021, 04:18 PM
Martin Michael RobertChief Business OfficerNov 11, 2021 Sale$29.0140,0001,160,28066,861Nov 12, 2021, 04:18 PM
Solomons NeilChief Medical OfficerNov 11, 2021 Option Exercise$5.30100,000530,000187,299Nov 12, 2021, 04:13 PM
Solomons NeilChief Medical OfficerNov 10, 2021 Option Exercise$5.83100,000583,200187,299Nov 12, 2021, 04:13 PM
Solomons NeilChief Medical OfficerNov 09, 2021 Sale$30.1750,0001,508,50087,299Nov 12, 2021, 04:13 PM
Solomons NeilChief Medical OfficerNov 11, 2021 Sale$28.89100,0002,889,00087,299Nov 12, 2021, 04:13 PM
Solomons NeilChief Medical OfficerNov 10, 2021 Sale$31.11100,0003,110,80097,299Nov 12, 2021, 04:13 PM
Solomons NeilChief Medical OfficerNov 01, 2021 Option Exercise$5.3045,000238,500182,299Nov 03, 2021, 04:24 PM
Solomons NeilChief Medical OfficerNov 01, 2021 Sale$31.6445,0001,423,800137,299Nov 03, 2021, 04:24 PM
Martin Michael RobertChief Business OfficerNov 01, 2021 Option Exercise$3.2045,000144,000221,861Nov 03, 2021, 04:20 PM
Martin Michael RobertChief Business OfficerNov 01, 2021 Sale$31.6445,0001,423,800176,861Nov 03, 2021, 04:20 PM
Huizinga Robert BindertEVP of ResearchOct 25, 2021 Option Exercise$3.2095,000304,000195,728Oct 26, 2021, 04:33 PM
Huizinga Robert BindertEVP of ResearchOct 25, 2021 Sale$29.75130,0003,867,50065,728Oct 26, 2021, 04:33 PM
Huizinga Robert BindertEVP of ResearchSep 21, 2021 Option Exercise$2.8627,13677,715133,228Sep 22, 2021, 04:53 PM
Huizinga Robert BindertEVP of ResearchSep 21, 2021 Sale$23.9932,500779,533106,092Sep 22, 2021, 04:53 PM
Martin Michael RobertChief Business OfficerSep 21, 2021 Option Exercise$7.4087,500647,750264,361Sep 22, 2021, 04:31 PM
Martin Michael RobertChief Business OfficerSep 20, 2021 Option Exercise$5.3028,500151,050205,361Sep 22, 2021, 04:31 PM
Martin Michael RobertChief Business OfficerSep 21, 2021 Sale$24.0287,5002,101,750176,861Sep 22, 2021, 04:31 PM
Martin Michael RobertChief Business OfficerSep 20, 2021 Sale$21.6528,500616,975192,861Sep 22, 2021, 04:31 PM
Martin Michael RobertChief Business OfficerSep 14, 2021 Option Exercise$5.3044,000233,200220,861Sep 16, 2021, 05:01 PM
Martin Michael RobertChief Business OfficerSep 14, 2021 Sale$21.7844,000958,220206,861Sep 16, 2021, 05:01 PM
Martin Michael RobertChief Business OfficerSep 14, 2021 Option Exercise$4.2590,000382,500266,861Sep 14, 2021, 06:16 PM
Martin Michael RobertChief Business OfficerSep 13, 2021 Option Exercise$5.3025,000132,500201,861Sep 14, 2021, 06:16 PM
Martin Michael RobertChief Business OfficerSep 14, 2021 Sale$21.1990,0001,907,217176,861Sep 14, 2021, 06:16 PM
Martin Michael RobertChief Business OfficerSep 10, 2021 Sale$19.8025,000495,000176,861Sep 14, 2021, 06:16 PM
Huizinga Robert BindertEVP of ResearchSep 10, 2021 Sale$19.8010,000197,950133,592Sep 14, 2021, 05:12 PM
Huizinga Robert BindertEVP of ResearchSep 14, 2021 Sale$21.7522,500489,375106,092Sep 14, 2021, 05:12 PM
Solomons NeilChief Medical OfficerSep 13, 2021 Option Exercise$3.20150,000480,000287,299Sep 14, 2021, 05:11 PM
Solomons NeilChief Medical OfficerSep 10, 2021 Sale$19.84150,0002,976,000137,299Sep 14, 2021, 05:11 PM
Martin Michael RobertChief Business OfficerSep 07, 2021 Sale$18.107,500135,750176,861Sep 08, 2021, 04:04 PM
Huizinga Robert BindertEVP of ResearchSep 07, 2021 Sale$18.305,00091,500138,592Sep 08, 2021, 04:03 PM
Martin Michael RobertChief Business OfficerAug 26, 2021 Sale$17.8122,500400,725184,361Aug 27, 2021, 04:09 PM
Solomons NeilChief Medical OfficerAug 25, 2021 Sale$15.855,00079,250137,299Aug 26, 2021, 04:15 PM
Solomons NeilChief Medical OfficerAug 09, 2021 Sale$16.0345,000721,350142,299Aug 10, 2021, 04:11 PM
Martin Michael RobertChief Business OfficerAug 09, 2021 Sale$16.015,00080,050206,861Aug 10, 2021, 04:09 PM
Martin Michael RobertChief Business OfficerJul 28, 2021 Sale$13.865,00069,300211,861Jul 29, 2021, 04:09 PM
Martin Michael RobertChief Business OfficerJun 22, 2021 Sale$13.765,00068,800216,861Jun 23, 2021, 04:06 PM
Donley Matthew MaxwellEx VP, Intern'l OperationsMay 11, 2021 Buy$10.079,90099,7399,900May 12, 2021, 04:34 PM
Greenleaf PeterChief Executive OfficerMay 11, 2021 Buy$10.715,12554,89113,453May 12, 2021, 04:32 PM
Solomons NeilChief Medical OfficerMar 12, 2021 Option Exercise$3.0240,000120,800227,299Mar 15, 2021, 04:36 PM
Solomons NeilChief Medical OfficerMar 12, 2021 Sale$13.4940,000539,600187,299Mar 15, 2021, 04:36 PM
MILNE GEORGE M JRDirectorMar 05, 2021 Buy$13.005,00065,00045,000Mar 09, 2021, 04:25 PM
Leversage JillDirectorJan 29, 2021 Buy$16.031,20019,2361,200Feb 02, 2021, 03:22 PM
Leversage JillDirectorJan 29, 2021 Buy$16.034006,412400Feb 02, 2021, 03:22 PM
Hayden Michael RDirectorJan 29, 2021 Option Exercise$5.7995,000550,10095,000Feb 02, 2021, 03:18 PM
Robertson Stephen P.EVP, General CounselJan 28, 2021 Buy$16.1490014,5262,720Jan 29, 2021, 12:24 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Greenleaf PeterChief Executive Officer03/06/2024711,094
Miller Joseph MChief Financial Officer03/06/2024194,942
Donley Matthew MaxwellEVP, Ops & Strategy03/06/2024224,064
Habig Scott MichaelChief Commercial Officer03/06/202499,551
Robertson Stephen P.EVP, General Counsel03/06/2024323,372
Knappertz VolkerEVP, Research and Development02/27/202430,073
Knappertz VolkerEVP, Research and Development02/20/2024137,800
Habig Scott MichaelChief Commercial Officer02/20/202486,951
Robertson Stephen P.EVP, General Counsel03/02/2023172,474
Miller Joseph MChief Financial Officer03/02/2023100,074
Jayne David R.W.Director05/23/202398,334
Hagan Joseph PDirector05/19/20232,878
Billen DanielDirector05/23/202352,359
MacKay-Dunn R. HectorDirector05/23/202354,251
Leversage JillDirector05/23/202354,217
MILNE GEORGE M JRDirector03/02/2023178,284
Miller Joseph MChief Financial Officer03/02/2023100,986
Robertson Stephen P.EVP, General Counsel03/02/2023173,454
Greenleaf PeterChief Executive Officer03/02/2023292,785
Donley Matthew MaxwellEx VP, Internal Operations11/21/202246,600
Habig Scott MichaelChief Commercial Officer11/09/202225,075
Martin Michael RobertChief Business Officer11/07/2022154,800
Jayne David R.W.Director05/18/202236,200
MacKay-Dunn R. HectorDirector03/09/202254,985
MILNE GEORGE M JRDirector03/04/202254,100
Martin Michael RobertChief Business Officer03/02/202258,236
Donley Matthew MaxwellEx VP, Intern'l Operations03/02/202236,655
Miller Joseph MChief Financial Officer03/02/202236,751
Colao MassimilanoChief Commercial Officer03/02/202238,492
Greenleaf PeterChief Executive Officer03/02/2022108,907
Solomons NeilChief Medical Officer03/02/202258,200
Huizinga Robert BindertEVP of Research03/02/202258,236
Leversage JillDirector12/13/202132,064
Martin Michael RobertChief Business Officer11/11/2021533,020
Martin Michael RobertChief Business Officer11/10/20211,868,500
Martin Michael RobertChief Business Officer11/09/20211,508,500
Martin Michael RobertChief Business Officer11/11/20211,160,280
Solomons NeilChief Medical Officer11/11/2021530,000
Solomons NeilChief Medical Officer11/10/2021583,200
Solomons NeilChief Medical Officer11/09/20211,508,500
Solomons NeilChief Medical Officer11/11/20212,889,000
Solomons NeilChief Medical Officer11/10/20213,110,800
Solomons NeilChief Medical Officer11/01/2021238,500
Solomons NeilChief Medical Officer11/01/20211,423,800
Martin Michael RobertChief Business Officer11/01/2021144,000
Martin Michael RobertChief Business Officer11/01/20211,423,800
Huizinga Robert BindertEVP of Research10/25/2021304,000
Huizinga Robert BindertEVP of Research10/25/20213,867,500
Huizinga Robert BindertEVP of Research09/21/202177,715
Huizinga Robert BindertEVP of Research09/21/2021779,533
Martin Michael RobertChief Business Officer09/21/2021647,750
Martin Michael RobertChief Business Officer09/20/2021151,050
Martin Michael RobertChief Business Officer09/21/20212,101,750
Martin Michael RobertChief Business Officer09/20/2021616,975
Martin Michael RobertChief Business Officer09/14/2021233,200
Martin Michael RobertChief Business Officer09/14/2021958,220
Martin Michael RobertChief Business Officer09/14/2021382,500
Martin Michael RobertChief Business Officer09/13/2021132,500
Martin Michael RobertChief Business Officer09/14/20211,907,217
Martin Michael RobertChief Business Officer09/10/2021495,000
Huizinga Robert BindertEVP of Research09/10/2021197,950
Huizinga Robert BindertEVP of Research09/14/2021489,375
Solomons NeilChief Medical Officer09/13/2021480,000
Solomons NeilChief Medical Officer09/10/20212,976,000
Martin Michael RobertChief Business Officer09/07/2021135,750
Huizinga Robert BindertEVP of Research09/07/202191,500
Martin Michael RobertChief Business Officer08/26/2021400,725
Solomons NeilChief Medical Officer08/25/202179,250
Solomons NeilChief Medical Officer08/09/2021721,350
Martin Michael RobertChief Business Officer08/09/202180,050
Martin Michael RobertChief Business Officer07/28/202169,300
Martin Michael RobertChief Business Officer06/22/202168,800
Donley Matthew MaxwellEx VP, Intern'l Operations05/11/202199,739
Greenleaf PeterChief Executive Officer05/11/202154,891
Solomons NeilChief Medical Officer03/12/2021120,800
Solomons NeilChief Medical Officer03/12/2021539,600
MILNE GEORGE M JRDirector03/05/202165,000
Leversage JillDirector01/29/202119,236
Leversage JillDirector01/29/20216,412
Hayden Michael RDirector01/29/2021550,100
Robertson Stephen P.EVP, General Counsel01/28/202114,526
Load More Insider Transactions
FUNDS WITH A POSITION IN AURINIA PHARMACEUTICALS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.8,921,0490.00204%6.05%Other
GEODE CAPITAL MANAGEMENT, LLC1,569,1360.00148%5.47%Other
BALYASNY ASSET MANAGEMENT L.P.887,0140.01%237.49%Event Driven
RENAISSANCE TECHNOLOGIES LLC135,0000.00188%-79.64%Other
D. E. SHAW & CO., INC.92,5620.00073%-74.08%Other
TIG ADVISORS, LLC268,7500.09%ExitedEvent Driven
ALPS ADVISORS INC100,5240.00711%-5%Other
AQR CAPITAL MANAGEMENT LLC21,4350.00036%15.2%Other
HARVEST MANAGEMENT LLC15,0000.06%ExitedEvent Driven
TUDOR INVESTMENT CORP ET AL13,5330.00105%ExitedEvent Driven, Other
HARVEST MANAGEMENT LLC10,000 (Put)0.04%ExitedEvent Driven
CHANGE IN SHARES OUTSTANDING FOR AURINIA PHARMACEUTICALS INC
STOCK BUYBACKS FOR AURINIA PHARMACEUTICALS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.59%
1Q
12/31/2023
06/30/2023
0.64%
2Q
12/31/2023
03/31/2023
0.73%
3Q
12/31/2023
12/31/2022
1.07%
4Q
12/31/2023
09/30/2022
1.29%
5Q
12/31/2023
06/30/2022
1.39%
6Q
12/31/2023
03/31/2022
1.42%
7Q
12/31/2023
12/31/2021
7.86%
8Q
12/31/2023
09/30/2021
11.87%
9Q
12/31/2023
06/30/2021
12.06%
10Q
12/31/2023
03/31/2021
12.78%
11Q
12/31/2023
12/31/2020
13.43%
12Q
12/31/2023
09/30/2020
17.43%
13Q
12/31/2023
06/30/2020
27.64%
14Q
12/31/2023
03/31/2020
28.05%
15Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.59%
1Q
06/30/2023
0.64%
2Q
03/31/2023
0.73%
3Q
12/31/2022
1.07%
4Q
09/30/2022
1.29%
5Q
06/30/2022
1.39%
6Q
03/31/2022
1.42%
7Q
12/31/2021
7.86%
8Q
09/30/2021
11.87%
9Q
06/30/2021
12.06%
10Q
03/31/2021
12.78%
11Q
12/31/2020
13.43%
12Q
09/30/2020
17.43%
13Q
06/30/2020
27.64%
14Q
03/31/2020
28.05%
15Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR AURINIA PHARMACEUTICALS INC
LOADING...